MiRNA-Based Therapies for Lung Cancer: Opportunities and Challenges?
Lung cancer is a commonly diagnosed cancer and the leading cause of cancer-related deaths, posing a serious health risk. Despite new advances in immune checkpoint and targeted therapies in recent years, the prognosis for lung cancer patients, especially those in advanced stages, remains poor. MicroR...
Main Authors: | Han Yang, Yufang Liu, Longqing Chen, Juanjuan Zhao, Mengmeng Guo, Xu Zhao, Zhenke Wen, Zhixu He, Chao Chen, Lin Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-05-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/13/6/877 |
Similar Items
-
MiRNA Deregulation Distinguishes Anaplastic Thyroid Carcinoma (ATC) and Supports Upregulation of Oncogene Expression
by: Danny Misiak, et al.
Published: (2021-11-01) -
miRNAs in the Regulation of Cancer Immune Response: Effect of miRNAs on Cancer Immunotherapy
by: Faheem Hyder Pottoo, et al.
Published: (2021-12-01) -
The Cystic Fibrosis Transmembrane Conductance Regulator Gene (CFTR) Is under Post-Transcriptional Control of microRNAs: Analysis of the Effects of agomiRNAs Mimicking miR-145-5p, miR-101-3p, and miR-335-5p
by: Chiara Papi, et al.
Published: (2023-04-01) -
Significance of MiRNA-34a and MiRNA-192 as a risk factor for nonalcoholic fatty liver disease
by: Halla M. Ragab, et al.
Published: (2023-02-01) -
Potential miRNAs for miRNA-Based Therapeutics in Breast Cancer
by: Jun Sheng Wong, et al.
Published: (2020-07-01)